Literature DB >> 8939971

Control of the translational regulators PHAS-I and PHAS-II by insulin and cAMP in 3T3-L1 adipocytes.

T A Lin1, J C Lawrence.   

Abstract

The eukaryotic initiation factor 4E (eIF-4E)-binding proteins PHAS-I and PHAS-II were found to have overlapping but different patterns of expression in tissues. Both PHAS proteins were expressed in 3T3-L1 adipocytes, in which insulin stimulated their phosphorylation, promoted dissociation of PHAS.eIF-4E complexes, and decreased the ability of both to bind exogenous eIF-4E. The effects of insulin were attenuated by rapamycin and wortmannin, two agents that block activation of p70(S6K). Unlike PHAS-I, PHAS-II was readily phosphorylated by cAMP-dependent protein kinase in vitro; however, the effects of insulin on both PHAS proteins were attenuated by agents that increase intracellular cAMP, by cAMP derivatives, and by phosphodiesterase inhibitors. These agents also markedly inhibited the activation of p70(S6K). In summary, our results indicate that PHAS-I and -II are controlled by the mammalian target of rapamycin and p70(S6K) signaling pathway and that in 3T3-L1 adipocytes this pathway is inhibited by increased cAMP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939971     DOI: 10.1074/jbc.271.47.30199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Protein-protein interaction panel using mouse full-length cDNAs.

Authors:  H Suzuki; Y Fukunishi; I Kagawa; R Saito; H Oda; T Endo; S Kondo; H Bono; Y Okazaki; Y Hayashizaki
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

2.  Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.

Authors:  Lingfei Hou; Eric Klann
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

3.  Functional characterization of a haplotype in the AKT1 gene associated with glucose homeostasis and metabolic syndrome.

Authors:  Brennan T Harmon; Stephanie A Devaney; Heather Gordish-Dressman; Erica K Reeves; Po Zhao; Joseph M Devaney; Eric P Hoffman
Journal:  Hum Genet       Date:  2010-09-26       Impact factor: 4.132

4.  Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.

Authors:  Xiaoying Hou; Edward W Arvisais; John S Davis
Journal:  Endocrinology       Date:  2010-03-29       Impact factor: 4.736

5.  Brief treatments with forskolin enhance s-phase entry in balance epithelia from the ears of rats.

Authors:  M Montcouquiol; J T Corwin
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

6.  RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.

Authors:  P E Burnett; R K Barrow; N A Cohen; S H Snyder; D M Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

7.  Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression.

Authors:  I Mothe-Satney; D Yang; P Fadden; T A Haystead; J C Lawrence
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.

Authors:  Sara Blancquaert; Lifu Wang; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Thurl E Harris; Pierre P Roger
Journal:  Mol Endocrinol       Date:  2010-05-19

9.  Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.

Authors:  Bertrand Léger; Romain Cartoni; Manu Praz; Séverine Lamon; Olivier Dériaz; Antoinette Crettenand; Charles Gobelet; Paul Rohmer; Michel Konzelmann; François Luthi; Aaron P Russell
Journal:  J Physiol       Date:  2006-08-17       Impact factor: 5.182

10.  Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes.

Authors:  T A Diggle; N T Redpath; K J Heesom; R M Denton
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.